Manipal Health Enterprises
add_icon

Manipal Health Enterprises IPO

IPO Open Now
₹14,000
0.45 xOver-subscribed
Bidding Dates 29 Jul, 26 -31 Jul, 26
Min Investment ₹14,000
Lot Size25
Price Range ₹560 – ₹590
Issue Size ₹9,275.22 Cr.
Download Doc
IPO Subscription Details
Retail Subscription Details
0.45 x
Non-Institutional Buyers (sHNI)
0.15 x
Non-Institutional Buyers (bHNI)
0.14 x
Qualified Institutional Buyers (QIB)
0.6 x
Employees
1.45 x
Total
0.45 x
IPO Timeline
IPO Offer Start
29 Jul,26
IPO Offer Ends
31 Jul,26
Allotment Finalisation
03 Aug,26
Refund Initiation
04 Aug,26
Listing of Shares
05 Aug,26

IPO Analysis

Strengths
Strenghts

The company is positioned as India’s largest pan-India multispecialty hospital network by bed capacity, with 13,037 beds across 14 states and union territories. It is also the second-largest hospital chain by number of hospitals and reported Fiscal 2026 revenue from operations of ₹103,357.51 million.

Strenghts

The company is the only private hospital chain network leading in Bengaluru, Kolkata and Pune by bed capacity, with 5,376 beds as of March 31, 2026. A balanced network is maintained, with 53.22% of licensed beds located outside metro cities.

Strenghts

The company’s brand is supported by 6.30 million patients served in Fiscal 2026 on a pro forma basis and multiple awards and recognitions. As of March 31, 2026, 11,064 doctors, 11,048 nurses and 6,362 paramedics were practicing across its hospitals.

Risks
Risk

The company derived 46.40%, 51.55%, and 59.98% of revenue from operations in Fiscals 2026, 2025 and 2024 respectively from hospitals in Karnataka. Any loss of business, disruption in operations, or geopolitical/policy changes in Karnataka could materially affect business performance and financial condition.

Risk

The company primarily generates revenue through inpatient care services. Any inability to maintain or improve admissions and hospital occupancy rates could adversely affect business operations. Current occupancy rates are 64.45% (Fiscal 2026) and 64.47% (Fiscal 2025).

Risk

The company derived 64.30%, 62.56% and 61.55% of gross inpatient revenue from cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics, and renal sciences in Fiscals 2026, 2025 and 2024 respectively. Negative changes in demand for these specialties could adversely impact business performance.

Objectives

The company proposes to utilize the Net Proceeds towards redemption of outstanding MHPL NCDs, payment of prepayment/early redemption penalties and accrued interest obligations. This will help reduce outstanding indebtedness and interest outflow, resulting in savings of interest costs.

The company proposes to utilize the Net Proceeds towards payment of the Base Purchase Consideration for acquisition of Tranche III of SHPL. This will enable the company to hold in aggregate 99.86% of SHPL, thereby consolidating and increasing ownership.

The general corporate purposes include strengthening marketing capabilities and brand building exercises, funding working capital requirements, meeting ongoing general corporate purposes or contingencies, and any other purpose as may be approved by the Board.

Yearly Financial Results

Annual Financials
Mar 2024
Mar 2025
Mar 2026
Revenue
6171.63
8242.25
10335.75
Expenses
5340.51
7134.43
9268.42
Other Income
93.54
120.54
184.77
Total Revenue
6265.17
8362.79
10520.52
Profit Before Tax
745.04
1242.31
1178.03
Net Profit
533.20
1081.67
916.52

Balance Sheet

Balance Sheet
Mar 2024
Mar 2025
Mar 2026
Total Assets
10818.83
14072.08
24864.50
Current Assets
2051.45
2848.12
4102.50
Fixed Assets
8760.88
11217.46
20755.51
Total Equity & Liabilities
10818.83
14072.08
24864.50
Total Liabilities
6731.32
8071.90
16065.74
Current Liabilities
1656.74
1794.80
3362.37
Non Current Liabilities
5074.58
6277.10
12703.37
Total Equity
4087.51
6000.18
8798.76

Cash Flow

Cash Flow
Mar 2024
Mar 2025
Mar 2026
Net Cash Flow
267.94
-184.43
-3.90
Investing Activities
-870.50
-2658.34
-7036.74
Operating Activities
1388.65
1569.83
2078.40
Financing Activities
-250.21
904.08
4954.44

About Manipal Health Enterprises

The company operates a pan-India network of multispecialty hospitals delivering comprehensive care services from outpatient services to complex tertiary and quaternary interventions. As of March 31, 2026, the company operated 49 hospitals with 13,037 licensed beds across 14 states and union territories, making it the largest pan-India multispecialty hospital network...more
Managing DirectorDilip Jose Puthiyidathu